| 吡柔比星预防膀胱癌复发77例 |
| |
| 引用本文： | 赵建军,韩成贤. 吡柔比星预防膀胱癌复发77例[J]. 蚌埠医学院学报, 2011, 36(5): 486-488 |
| |
| 作者姓名： | 赵建军 韩成贤 |
| |
| 作者单位： | 安徽省宿州市第一人民医院泌尿外科, 234000 |
| |
| 摘 要： | 目的:探讨预防膀胱癌术后复发更有效的方法。方法:术中系统采用吡柔比星液行肿瘤基底及切缘注射,浸泡膀胱和切口,术后膀胱灌注吡柔比星液。结果:随访6~60个月,1、2、3、4、5年复发率分别为18.2%、6.4%、1.3%、1.3%和0.6%,无一例发生切口种植转移及严重并发症。结论:术中、术后应用吡柔比星预防膀胱癌术后复发安全有效。
|
| 关 键 词： | 膀胱肿瘤 药物治疗 吡柔比星 预防 |
| 收稿时间： | 2011-01-12 |
Clinical research of pirarubicin in the prevention of bladder carcinoma:report of 77 cases |
| |
| ZHAO Jian-jun,HAN Cheng-xian. Clinical research of pirarubicin in the prevention of bladder carcinoma:report of 77 cases[J]. Journal of Bengbu Medical College, 2011, 36(5): 486-488 |
| |
| Authors: | ZHAO Jian-jun HAN Cheng-xian |
| |
| Affiliation: | Department of Urology, Suzhou First People's Hospital, Suzhou Anhui 234000, China |
| |
| Abstract: | Objective:To investigate the more effective cure for the postoperative recurrence of bladder carcinoma.Methods:Seventy-seven patients were treated with tumor base injection,bladder incisional margin injection,bladder cavity and incision immersion intraoperatively,postoperation with the intravesical instillation of pirarubicin.Results:The follow-up survey was for six months-sixty months.The total recurrence rate is 28.6%,and recurrence rate of 1-5 years is showed apart as 18.2% 6.4% 1.3%,1.3% and 0.6%.Neithe... |
| |
| Keywords: | bladder neoplasms drug treatment pirarubicin prevention |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
| 点击此处可从《蚌埠医学院学报》浏览原始摘要信息 |
|
点击此处可从《蚌埠医学院学报》下载全文 |
|
